Home▸Articles▸Aging & Longevity Science

Cellular Senescence and Senolytic Screening: Understanding Aging at a Molecular Level

Cellular senescence is a critical mechanism in aging, and senolytics offer potential therapeutic strategies to combat age-related diseases.

mysimulator teamUpdated June 2026≈ 3 min read▶ Open the simulation

What is Cellular Senescence

Cellular senescence refers to a state in which cells stop dividing, often as a response to DNA damage or other stressors. These cells enter a permanent growth arrest and can secrete pro-inflammatory cytokines and matrix metalloproteinases known as the senescence-associated secretory phenotype (SASP).

Senescent cells accumulate with age and contribute to tissue dysfunction, inflammation, and the development of various age-related diseases.

The SASP Phenotype

The senescence-associated secretory phenotype (SASP) is a complex mix of cytokines, chemokines, growth factors, and proteases. These molecules can promote inflammation, fibrosis, and tissue remodeling.

Understanding the SASP helps in developing targeted therapies to reduce its harmful effects while preserving beneficial aspects.

live demo · related simulation● LIVE

Senolytics: Targeting Senescent Cells

Senolytics are drugs or compounds designed to selectively eliminate senescent cells. By targeting these 'zombie cells', senolytics aim to improve tissue function and reduce age-related diseases.

Several classes of senolytic agents have been identified, including BCL-2 family inhibitors, PI3K/mTOR pathway modulators, and ROS-generating compounds.

Screening Senolytics

Screening for effective senolytics involves testing various compounds in vitro to determine their ability to selectively kill senescent cells without harming healthy cells.

This process is crucial for identifying safe and efficient treatments that can be translated into clinical applications.

Frequently asked questions

What are the potential benefits of targeting senescent cells with senolytics?

Targeting senescent cells with senolytics could potentially improve tissue function, reduce inflammation, and delay age-related diseases such as osteoarthritis, diabetes, and cardiovascular disease.

How do senolytics work to eliminate senescent cells?

Senolytics typically induce apoptosis in senescent cells by targeting specific signaling pathways or proteins that are upregulated in these cells. This selective elimination helps reduce the SASP and improve tissue health.

Are there any risks associated with using senolytics?

While generally safe, senolytics can potentially cause side effects such as increased oxidative stress or off-target toxicity if not properly optimized for selectivity and efficacy.

Can senolytics be used to reverse aging in humans?

Current research suggests that senolytics may help delay age-related diseases but reversing the entire process of aging is still a distant goal. Further studies are needed to understand their long-term effects and potential for rejuvenation.

Try it live

Everything above runs in your browser — open Cellular Senescence & Senolytic Screening and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.

▶ Open Cellular Senescence & Senolytic Screening simulation

What did you find?

Add reproduction steps (optional)